CSS LLC’s Inovio Pharmaceuticals INO Stock Holding History

CSS LLC’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-417	Closed	-$58K	–	887
2020 Q3	$58K	Sell	417 -1,716	-80%	-$358K	﹤0.01%	704
2020 Q2	$689K	Buy	2,133 +2,000	+1,504%	+$321K	0.04%	330
2020 Q1	$11K	Buy	+133	New	+$8.2K	﹤0.01%	574

Other funds holding INO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CSS LLC's INO Position: Q2 2021 in Review

CSS LLC sold out of Inovio Pharmaceuticals (INO) in Q2 2021, closing a stake of 108 shares — an estimated $12K sold.

CSS LLC first reported a position in INO in Q1 2020 and held it in 2 quarters. The position peaked at $12K in Q1 2021. 211 funds tracked by Wall St. Rank hold INO as of Q2 2021.

CSS LLC reported no remaining Inovio Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
CSS LLC sold 108 Inovio Pharmaceuticals shares in Q2 2021, an estimated $12K.
CSS LLC first reported a position in Inovio Pharmaceuticals in Q1 2020 and held it in 2 quarters.
CSS LLC's Inovio Pharmaceuticals position peaked at $12K in Q1 2021.
211 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2021.

Based on CSS LLC's 13F filing for Q2 2021, filed 16 Aug 2021.